A Novel Probe Technology for Detecting Native Albumin Activity as a Biomarker in Patients with Hepatitis B-related Cirrhosis and Hepatocellular Carcinoma and Its Clinical Applications
Albumin is a major prognostic factor for patients with advanced liver disease, dependent on its concentration and biological activity. This study aimed to improve the method of active albumin detection and elucidate its predictive validity of albumin activity across hepatic disease progression and etiology.
Authors
- Mingyu Duan (ORCID: https://orcid.org/0000-0002-8413-6751)
- Zhaozhe Liu (ORCID: https://orcid.org/0000-0002-3859-8285)
- Jiaming Qian (ORCID: https://orcid.org/0000-0002-9110-4950)
- M Li
- Fengyang Chen (ORCID: https://orcid.org/0000-0003-4490-8443)
- Xing Liu (ORCID: https://orcid.org/0000-0002-1301-4837)
- Xinyue Li (ORCID: https://orcid.org/0000-0001-7362-0532)
- Guoliang Chen (ORCID: https://orcid.org/0000-0003-3674-5226)
- Xuan Liang (ORCID: https://orcid.org/0000-0002-1062-4103)
- Ye Gu (ORCID: https://orcid.org/0000-0002-1415-7119)
- Xiaofeng Wu (ORCID: https://orcid.org/0000-0003-4501-1101)
- Yan Wang (ORCID: https://orcid.org/0000-0001-7791-0238)
- Tianyue Chen
- Linge Zhang
- Cheng Lv
Publication Details
- Journal
- Future Integrative Medicine
- Published
- 2024-08-30
- DOI
- https://doi.org/10.14218/fim.2024.00022
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00